Director, Business Development, YUMAB
Head of Business Development, RubrYc Therapeutics
Group Leader, Research and Development, Bristol Myers Squibb
David is the Head of Business Development at AbTherx. He has held senior positions in business development and biologics drug discovery for over 20 years. David served as the US Business Development representative for YUMAB, an antibody discovery CRO based in Germany. Prior to YUMAB, he led business development and operations at RubrYc Therapeutics. David gained broad experience in therapeutic antibody discovery and early development as a Group Leader at Medarex/BMS for 15 years.
David received his MBA from Pepperdine University and his BSc from California State University Fresno.